11,Kruskal JB,CommerfordPJ,Franks JJ,et al.Fibrin and fibrinogen-rela ted antigens in patients with stable andunstable coronary disease.N Eng J Med ,1987,317(4):1361
22,Aramoto H,Shigematsu H,Muto T.Perioperative changes is co-agulati ve and fibrinolytic function during surgical treatment of abdominal aortic aneurysm and arteriosclerosis obliterans.Int J Cardiol,1994,47(1 Suppl):S55-63
33,Tanaka M,Suzuki A.Hemostatic abnormalities in acute myocardial infar ction as detectedby specific blood markers.Thromb Res,1994,76(3):289-98
44,Vaziri NDL,Kennedy SC,Kennedy D,et al.Coagulation,fibri-nolytic a nd inhibitory proteins in acute myocardial infarction and angina pectoris. Am JMed,1992,93(6):651-657
55,Eisenberg PR,Jaffe AS,Stump DC,et al.Validity of enzy-me linked i mmunosorbent assays of cross-linked fibrin degradation products as a easure ofclot lysis.Circulation,1990,82(4):1159-1168
66,Lawler CM,Bovill EG,Stump DC,et al.Fibrin fragment D-dimer and fibr inogen B betapeptides in plasma as markers of clot lysis during thrombolytic th erapy in acutemyocardial infarction.Blood,1990,76(7):1341-1348
收稿:1999-06-11修回:2000-03-11
7Boushey CJ, Beresford SA, Omenn CS, et al. A quantitative asses sement of plasma homocysteine as a rick factor for vascular disease [J]. JAMA,1995,274(13) :1049 - 1057.
8Nygard O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease[J ]. N Engl J Med, 1997,337(40) .-230 - 236.